Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protozoal mitochondrial respiratory chain enzymes are a group of protein complexes located in the inner mitochondrial membrane of parasitic protozoa, such as Plasmodium, Trypanosoma, and Leishmania species. These enzymes, including the cytochrome bc1 complex (Complex III) and the alternative oxidase (AOX), are essential for the electron transport chain (ETC), which generates the proton gradient required for ATP synthesis and the maintenance of the mitochondrial membrane potential (Mather et al., 2007, PubMed: 17091205). In many protozoa, particularly the malaria parasite Plasmodium falciparum, the primary role of the respiratory chain is not ATP production but rather the regeneration of ubiquinone, which serves as an electron acceptor for dihydroorotate dehydrogenase (DHODH), a key enzyme in de novo pyrimidine biosynthesis (Painter et al., 2007, PubMed: 17314980). Because these protozoal enzymes often possess unique structural features or alternative pathways absent in humans, they are highly effective targets for selective chemotherapy. For example, the drug atovaquone binds to the cytochrome b subunit of the bc1 complex, effectively halting electron flow and causing parasite death by collapsing the membrane potential (Srivastava et al., 1997, PubMed: 9313111). However, the clinical utility of targeting these enzymes is frequently challenged by the rapid development of resistance, often mediated by single nucleotide polymorphisms in the mitochondrial DNA (Fisher et al., 2012, PubMed: 22230238).
Inhibition of electron transfer within the mitochondrial respiratory chain, leading to the collapse of the mitochondrial membrane potential and the subsequent inhibition of essential metabolic pathways such as de novo pyrimidine biosynthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protozoal mitochondrial respiratory chain enzymes.